Daiichi Sankyo's R&D expenditure FY 2013-2022
In the fiscal year 2022, Daiichi Sankyo Co., Ltd. spent approximately 341.6 billion Japanese yen on research and development (R&D), up from around 260 billion Japanese yen in the previous fiscal year. The main products of the Japanese pharmaceutical company include oncology medications, cardiovascular medications, and vaccines.